Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 12/20 | 0.54 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.50 |
| ▸ | KDM4A | O75164 | 2/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.50 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.50 |
| ▸ | TET3 | O43151 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.48 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.48 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10603309 | 0.85 | LMNA (0.46) | FOLH1TET2KDM4AKDM4CKDM2A | |
| SCHEMBL669817 | 0.83 | FOLH1 (0.64) | FOLH1TET2KDM4AKDM4CKDM2A | |
| SCHEMBL27473595 | 0.78 | FOLH1 (0.58) | FOLH1TET2KDM4AKDM4CKDM2A | |
| SCHEMBL509039 | 0.74 | FOLH1 (0.54) | FOLH1TET2KDM4AKDM4CKDM2A | |
| SCHEMBL11056280 | 0.74 | TET2 (0.64) | FOLH1TET2KDM4AKDM4CKDM2A | |
| SCHEMBL7000281 | 0.74 | CYP1A2 (0.54) | FOLH1TET2KDM4AKDM4CKDM2A | |
| SCHEMBL1377274 | 0.74 | CYP1A2 (0.54) | FOLH1TET2KDM4AKDM4CKDM2A | |
| SCHEMBL4321051 | 0.72 | TDP1 (0.48) | FOLH1TET2TET3GRIK1GRIK2 | |
| SCHEMBL1052505 | 0.72 | TDP1 (0.48) | FOLH1TET2TET3GRIK1GRIK2 | |
| SCHEMBL301073 | 0.72 | CYP1A2 (0.65) | TET2KDM4AKDM4CKDM2ATET3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1588736-A2 | Microperfusive electrical stimulation | Zoll Medical Corporation (US) | 2005-10-26 | — | — | EP | claimed |
| EP-4642757-A1 | PROCESS FOR TREATING KERATIN MATERIALS USING AT LEAST ONE OIL BEARING ACETOACETATE FUNCTIONS AND AT LEAST ONE CROSSLINKING AGENT | L'OREAL (FR) | 2025-11-05 | — | — | EP | disclosed |
| EP-4642759-A1 | PROCESS FOR TREATING KERATIN FIBRES USING AT LEAST ONE OIL BEARING ACETOACETATE FUNCTIONS | L'OREAL (FR) | 2025-11-05 | — | — | EP | disclosed |
| WO-2025109174-A1 | COMPOSITION IN THE FORM OF A DIRECT EMULSION COMPRISING AT LEAST ONE COMPOUND BEARING ACETOACETATE FUNCTIONS, AT LEAST ONE FATTY ACID AND AT LEAST CHITOSAN | L'OREAL (FR) | 2025-05-30 | — | — | WO | disclosed |
| WO-2024141523-A1 | PROCESS FOR TREATING KERATIN FIBRES USING AT LEAST ONE OIL BEARING ACETOACETATE FUNCTIONS | L'OREAL (FR) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024141524-A1 | PROCESS FOR TREATING KERATIN MATERIALS USING AT LEAST ONE OIL BEARING ACETOACETATE FUNCTIONS AND AT LEAST ONE CROSSLINKING AGENT | L'OREAL (FR) | 2024-07-04 | — | — | WO | disclosed |
| US-8663342-B2 | Process for producing nitrogen-containing composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| EP-2685259-A1 | A method of diagnosing an asthma disease state | The Governors of the University of Alberta (CA) | 2014-01-15 | — | — | EP | disclosed |
| EP-2331955-B1 | Diagnosis of an asthma disease state | UNIV ALBERTA (CA) | 2013-10-30 | — | — | EP | disclosed |
| US-20130177495-A1 | NITROGEN-CONTAINING COMPOSITION AND PROCESS FOR PRODUCING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-07-11 | — | — | US | disclosed |
| EP-2431071-A1 | Microperfusive electrical stimulation | Zoll Medical Corporation (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20110238319-A1 | METHOD OF DIAGNOSING A RESPIRATORY DISEASE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2011-09-29 | — | — | US | disclosed |
| EP-2331955-A1 | A METHOD OF DIAGNOSING A RESPIRATORY DISEASE | The Governors of the University of Alberta (CA) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010020058-A1 | A METHOD OF DIAGNOSING A RESPIRATORY DISEASE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2010-02-25 | — | — | WO | disclosed |
| EP-1199368-B1 | Use of adenoviral e4 reading frames to improve expression of a gene of interest | TRANSGENE SA (FR) | 2004-01-21 | — | — | EP | disclosed |
| US-6475480-B1 | Use of adenoviral E4 reading frames to improve expression of a gene of interest | TRANSGENE S.A. (FR) | 2002-11-05 | — | — | US | disclosed |
| EP-0974668-B1 | Use of adenoviral E4 reading frames to improve expression of a gene of interest | TRANSGENE SA (FR) | 2002-10-02 | — | — | EP | disclosed |
| EP-1199368-A2 | Use of adenoviral e4 reading frames to improve expression of a gene of interest | TRANSGENE S.A. (FR) | 2002-04-24 | — | — | EP | disclosed |
| EP-0974668-A1 | Use of adenoviral E4 reading frames to improve expression of a gene of interest | TRANSGENE S.A. (FR) | 2000-01-26 | — | — | EP | disclosed |